TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Acura Pharmaceuticals ( (ACUR) ).
Acura Pharmaceuticals has received multiple loans from Abuse Deterrent Pharma, LLC, totaling $8,994,279 as of October 23, 2025, with accrued interest of approximately $865,000. These funds are intended to support daily operations, but without additional financing by early November 2025, Acura may need to reduce operations or consider bankruptcy, potentially leading to a total loss of shareholder value.
More about Acura Pharmaceuticals
Technical Sentiment Signal: Sell
Current Market Cap: $26.4K
For a thorough assessment of ACUR stock, go to TipRanks’ Stock Analysis page.